FOXM1 acts as a transcriptional regulator of promoting cell cycle advancement, while GLUT1 serves as a carrier for glucose uptake viaglycolysis, particularly in tumors and often connected to cancer phenotypes. Here, SLC2A1 is linked to cancer.